<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biosignaling.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Cell Communication and Signaling - Latest Articles</title>
        <link>http://www.biosignaling.com</link>
        <description>The latest research articles published by Cell Communication and Signaling</description>
        <dc:date>2009-06-18T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/15" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/14" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/13" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/12" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/11" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/10" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/9" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/8" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/7" />
                                <rdf:li rdf:resource="http://www.biosignaling.com/content/7/1/6" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biosignaling.com/content/7/1/15">
        <title>Activin signaling as an emerging target for therapeutic interventions</title>
        <description>After the initial discovery of activins as important regulators of reproduction, novel and diverse roles have been unraveled for them. Activins are expressed in various tissues and have a broad range of activities including the regulation of gonadal function, hormonal homeostasis, growth and differentiation of musculoskeletal tissues, regulation of growth and metastasis of cancer cells, proliferation and differentiation of embryonic stem cells, and even higher brain functions. Activins signal through a combination of type I and II transmembrane serine/threonine kinase receptors. Activin receptors are shared by multiple transforming growth factor-beta (TGF-beta) ligands such as myostatin, growth and differentiation factor-11 and nodal. Thus, although the activity of each ligand is distinct, they are also redundant, both physiologically and pathologically in vivo. Activin receptors activated by ligands phosphorylate the receptor-regulated Smads for TGF-beta, Smad2 and 3. The Smad proteins then undergo multimerization with the co-mediator Smad4, and translocate into the nucleus to regulate the transcription of target genes in cooperation with nuclear cofactors. Signaling through receptors and Smads is controlled by multiple mechanisms including phosphorylation and other posttranslational modifications such as sumoylation, which affect potein localization, stability and transcriptional activity. Non-Smad signaling also plays an important role in activin signaling. Extracellularly, follistatin and related proteins bind to activins and related TGF-beta ligands, and control the signaling and availability of ligands.The functions of activins through activin receptors are pleiotrophic, cell type-specific and contextual, and they are involved in the etiology and pathogenesis of a variety of diseases. Accordingly, activin signaling may be a target for therapeutic interventions. In this review, we summarize the current knowledge on activin signaling and discuss the potential roles of this pathway as a molecular target of therapy for metabolic diseases, musculoskeletal disorders, cancers and neural damages.</description>
        <link>http://www.biosignaling.com/content/7/1/15</link>
                <dc:creator>Kunihiro Tsuchida</dc:creator>
                <dc:creator>Masashi Nakatani</dc:creator>
                <dc:creator>Keisuke Hitachi</dc:creator>
                <dc:creator>Akiyoshi Uezumi</dc:creator>
                <dc:creator>Yoshihide Sunada</dc:creator>
                <dc:creator>Hiroshi Ageta</dc:creator>
                <dc:creator>Kaoru Inokuchi</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, 7:15</dc:source>
        <dc:date>2009-06-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-15</dc:identifier>
        <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2009-06-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/14">
        <title>Expression and function of the insulin receptor substrate proteins in cancer</title>
        <description>The Insulin Receptor Substrate (IRS) proteins are cytoplasmic adaptor proteins that function as essential signaling intermediates downstream of activated cell surface receptors, many of which have been implicated in cancer.  The IRS proteins do not contain any intrinsic kinase activity, but rather serve as scaffolds to organize signaling complexes and initiate intracellular signaling pathways.  As common intermediates of multiple receptors that can influence tumor progression, the IRS proteins are positioned to play a pivotal role in regulating the response of tumor cells to many different microenvironmental stimuli.  Limited studies on IRS expression in human tumors and studies on IRS function in human tumor cell lines and in mouse models have provided clues to the potential function of these adaptor proteins in human cancer.  A general theme arises from these studies; IRS-1 and IRS-4 are most often associated with tumor growth and proliferation and IRS-2 is most often associated with tumor motility and invasion.  In this review, we discuss the mechanisms by which IRS expression and function are regulated and how the IRS proteins contribute to tumor initiation and progression.</description>
        <link>http://www.biosignaling.com/content/7/1/14</link>
                <dc:creator>Katerina Mardilovich</dc:creator>
                <dc:creator>Shannon Pankratz</dc:creator>
                <dc:creator>Leslie Shaw</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, 7:14</dc:source>
        <dc:date>2009-06-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-14</dc:identifier>
        <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2009-06-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/13">
        <title>Crk and CrkL adaptor proteins: networks for physiological and pathological signaling</title>
        <description>The Crk adaptor proteins (Crk and CrkL) constitute an integral part of a network of essential signal transduction pathways in humans and other organisms that act as major convergence points in tyrosine kinase signaling. Crk proteins integrate signals from a wide variety of sources, including growth factors, extracellular matrix molecules, bacterial pathogens, and apoptotic cells. Mounting evidence indicates that dysregulation of Crk proteins is associated with human diseases, including cancer and susceptibility to pathogen infections. Recent structural work has identified new and unusual insights into the regulation of Crk proteins, providing a rationale for how Crk can sense diverse signals and produce a myriad of biological responses.</description>
        <link>http://www.biosignaling.com/content/7/1/13</link>
                <dc:creator>Raymond Birge</dc:creator>
                <dc:creator>Charalampos Kalodimos</dc:creator>
                <dc:creator>Fuyuhiko Inagaki</dc:creator>
                <dc:creator>Shinya Tanaka</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, 7:13</dc:source>
        <dc:date>2009-05-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-13</dc:identifier>
        <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2009-05-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/12">
        <title>The receptor RAGE: Bridging inflammation and cancer</title>
        <description>The receptor for advanced glycation end products (RAGE) is a single transmembrane receptor of the immunoglobulin superfamily that is mainly expressed on immune cells, neurons, activated endothelial and vascular smooth muscle cells, bone forming cells, and a variety of cancer cells. RAGE is a multifunctional receptor that binds a broad repertoire of ligands and mediates responses to cell damage and stress conditions. It activates programs responsible for acute and chronic inflammation, and is implicated in a number of pathological diseases, including diabetic complications, stroke, atheriosclerosis, arthritis, and neurodegenerative disorders. The availability of Rage knockout mice has not only advanced our knowledge on signalling pathways within these pathophysiological conditions, but also on the functional importance of the receptor in processes of cancer. Here, we will summarize molecular mechanisms through which RAGE signalling contributes to the establishment of a pro-tumourigenic microenvironment. Moreover, we will review recent findings that provide genetic evidence for an important role of RAGE in bridging inflammation and cancer.</description>
        <link>http://www.biosignaling.com/content/7/1/12</link>
                <dc:creator>Astrid Riehl</dc:creator>
                <dc:creator>Julia Nemeth</dc:creator>
                <dc:creator>Peter Angel</dc:creator>
                <dc:creator>Jochen Hess</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, 7:12</dc:source>
        <dc:date>2009-05-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-12</dc:identifier>
        <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2009-05-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/11">
        <title>Distinct phosphorylation requirements regulate cortactin activation by TirEPEC and its binding to N-WASP.</title>
        <description>Background:
Cortactin activates the actin-related 2/3 (Arp2/3) complex promoting actin polymerization to remodel cell architecture in multiple processes (e.g. cell migration, membrane trafficking, invadopodia formation etc.). Moreover, it was called the Achilles&apos; heel of the actin cytoskeleton because many pathogens hijack signals that converge on this oncogenic scaffolding protein. Cortactin is able to modulate N-WASP activation in vitro in a phosphorylation-dependent fashion. Thus Erk-phosphorylated cortactin is efficient in activating N-WASP through its SH3 domain, while Src-phosphorylated cortactin is not. This could represent a switch on/off mechanism controlling the coordinated action of both nucleator promoting factors (NPFs). Pedestal formation by enteropathogenic Escherichia coli (EPEC) requires N-WASP activation. N-WASP is recruited by the cell adapter Nck which binds a major tyrosine-phosphorylated site of a bacterial injected effector, Tir (translocated intimin receptor). Tir-Nck-N-WASP axis defines the current major pathway to actin polymerization on pedestals. In addition, it was recently reported that EPEC induces tyrosine phosphorylation of cortactin.
Results:
Here we demonstrate that cortactin phosphorylation is absent on N-WASP deficient cells, but is recovered by re-expression of N-WASP. We used purified recombinant cortactin and Tir proteins to demonstrate a direct interaction of both that promoted Arp2/3 complex-mediated actin polymerization in vitro, independently of cortactin phosphorylation.
Conclusion:
We propose that cortactin binds Tir through its N-terminal part in a tyrosine and serine phosphorylation independent manner while SH3 domain binding and activation of N-WASP is regulated by tyrosine and serine mediated phosphorylation of cortactin. Therefore cortactin could act on Tir-Nck-N-WASP pathway and control a possible cycling activity of N-WASP underlying pedestal formation.</description>
        <link>http://www.biosignaling.com/content/7/1/11</link>
                <dc:creator>Elvira Nieto-Pelegrin</dc:creator>
                <dc:creator>Narcisa Martinez-Quiles</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, 7:11</dc:source>
        <dc:date>2009-05-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-11</dc:identifier>
        <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2009-05-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/10">
        <title>Src, PKCalpha, and PKCdelta are required for alphavbeta3 integrin-mediated metastatic melanoma invasion</title>
        <description>Background:
Integrins, cell-surface receptors that mediate adhesive interactions between cells and the extracellular matrix (ECM), play an important role in cancer progression. Expression of the vitronectin receptor &#945;v&#946;3 integrin correlates with increased invasive and metastatic capacity of malignant melanomas, yet it remains unclear how expression of this integrin triggers melanoma invasion and metastasis.
Results:
Two melanoma cell lines C8161.9 and M14 both express high levels of &#945;v&#946;3 integrin and adhere to vitronectin. However, only the highly metastatic C8161.9 cells are capable of invading vitronectin-enriched Matrigel in an &#945;v&#946;3-depenent manner. Elevated levels of PKC&#945; and PKC&#948;, and activated Src were detected specifically in the highly metastatic melanoma cells, but not in the low metastatic M14 cells. Inhibition of Src or PKC activity suppressed &#945;v&#946;3-dependent invasion. Furthermore, over expression of Src or PKC&#945; and PKC&#948; was sufficient to confer &#945;v&#946;3-dependent invasiveness to M14 cells. Stress fiber formation and focal adhesion formation were almost completely absent in C8161.9 cells compared to M14 cells. Inhibition of Src signaling was sufficient to restore normal actin architecture, and resulted in decreased p190RhoGAP phosphorylation and enhanced RhoA activity. Src had no effect on Rac activity. Loss of PKC&#945; expression, but not PKC&#948;, by siRNA inhibited Rac and PAK activity as well as invasiveness. Loss of PKC&#945; restored focal adhesion formation and partially restored stress fiber formation, while loss of PKC&#948; primarily restored stress fibers.
Conclusion:
The misregulated expression of PKC&#945; and PKC&#948; and elevated Src activity in metastatic melanoma cells is required for efficient &#945;v&#946;3-mediated invasion. PKC&#945; and Src enhance &#945;v&#946;3-mediated invasion in part by increasing the GTPase activity of Rac relative to RhoA. PKC&#945; influences focal adhesion formation, while PKC&#948; controls stress fibers.</description>
        <link>http://www.biosignaling.com/content/7/1/10</link>
                <dc:creator>Andrew Putnam</dc:creator>
                <dc:creator>Veronique Schulz</dc:creator>
                <dc:creator>Eric Freiter</dc:creator>
                <dc:creator>Heather Bill</dc:creator>
                <dc:creator>Cindy Miranti</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, 7:10</dc:source>
        <dc:date>2009-04-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-10</dc:identifier>
        <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2009-04-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/9">
        <title>The roles of ASK family proteins in stress responses and diseases</title>
        <description>Apoptosis signal-regulating kinase 1 (ASK1) is a member of the mitogen-activated protein kinase kinase kinase family, which activates c-Jun N-terminal kinase and p38 in response to a diverse array of stresses such as oxidative stress, endoplasmic reticulum stress and calcium influx. In the past decade, various regulatory mechanisms of ASK1 have been elucidated, including its oxidative stress-dependent activation. Recently, it has emerged that ASK family proteins play key roles in cancer, cardiovascular diseases and neurodegenerative diseases. In this review, we summarize the recent findings on ASK family proteins and their implications in various diseases.</description>
        <link>http://www.biosignaling.com/content/7/1/9</link>
                <dc:creator>Kazuki Hattori</dc:creator>
                <dc:creator>Isao Naguro</dc:creator>
                <dc:creator>Christopher Runchel</dc:creator>
                <dc:creator>Hidenori Ichijo</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, 7:9</dc:source>
        <dc:date>2009-04-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-9</dc:identifier>
        <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2009-04-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/8">
        <title>Regulation of cellular proliferation, differentiation and cell death by activated Raf </title>
        <description>The protein kinases Raf-1, A-Raf and B-Raf connect receptor stimulation with intracellular signaling pathways and function as a central intermediate in many signaling pathways. Gain-of-function experiments shed light on the pleiotropic biological activities of these enzymes. Expression experiments involving constitutively active Raf revealed the essential functions of Raf in controlling proliferation, differentiation and cell death in a cell-type specific manner.</description>
        <link>http://www.biosignaling.com/content/7/1/8</link>
                <dc:creator>Gerald Thiel</dc:creator>
                <dc:creator>Myriam Ekici</dc:creator>
                <dc:creator>Oliver Rossler</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, 7:8</dc:source>
        <dc:date>2009-04-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-8</dc:identifier>
        <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2009-04-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/7">
        <title>Obituary: Hidesaburo Hanafusa 1929-2009</title>
        <description>Hidesaburo Hanafusa, an eminent figure in the areas of virology, cancer signalling and protein interaction module research passed away at age 79 on 15 March 2009. His pioneering research provided the groundwork for the discovery of the first oncogene and also introduced protein - protein interactions as a novel concept in oncogenic signalling.</description>
        <link>http://www.biosignaling.com/content/7/1/7</link>
                <dc:creator>Stephan Feller</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, 7:7</dc:source>
        <dc:date>2009-04-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-7</dc:identifier>
        <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2009-04-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biosignaling.com/content/7/1/6">
        <title>Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord</title>
        <description>Background:
A variety of cell types can be identified in the adherent fraction of bone marrow mononuclear cells including more primitive and embryonic-like stem cells, mesenchymal stem cells (MSC), lineage-committed progenitors as well as mature cells such as osteoblasts and fibroblasts. Different methods are described for the isolation of single bone marrow stem cell subpopulations &#8211; beginning from ordinary size sieving, long term cultivation under specific conditions to FACS-based approaches. Besides bone marrow-derived subpopulations, also other tissues including human umbilical cord (UC) have been recently suggested to provide a potential source for MSC. Although of clinical importance, these UC-derived MSC populations remain to be characterized. It was thus the aim of the present study to identify possible subpopulations in cultures of MSC-like cells obtained from UC. We used counterflow centrifugal elutriation (CCE) as a novel strategy to successfully address this question.
Results:
UC-derived primary cells were separated by CCE and revealed differentially-sized populations in the fractions. Thus, a subpopulation with an average diameter of about 11 &#956;m and a small flat cell body was compared to a large sized subpopulation of about 19 &#956;m average diameter. Flow cytometric analysis revealed the expression of certain MSC stem cell markers including CD44, CD73, CD90 and CD105, respectively, although these markers were expressed at higher levels in the small-sized population. Moreover, this small-sized subpopulation exhibited a higher proliferative capacity as compared to the total UC-derived primary cultures and the large-sized cells and demonstrated a reduced amount of aging cells.
Conclusion:
Using the CCE technique, we were the first to demonstrate a subpopulation of small-sized UC-derived primary cells carrying MSC-like characteristics according to the presence of various mesenchymal stem cell markers. This is also supported by the high proliferative capacity of these MSC-like cells as compared to whole primary culture or other UC-derived subpopulations. The accumulation of a self-renewing MSC-like subpopulation by CCE with low expression levels of the aging marker senescence-associated &#946;-galactosidase provides a valuable tool in the regenerative medicine and an alternative to bone-marrow-derived MSC.</description>
        <link>http://www.biosignaling.com/content/7/1/6</link>
                <dc:creator>Ingrida Majore</dc:creator>
                <dc:creator>Pierre Moretti</dc:creator>
                <dc:creator>Ralf Hass</dc:creator>
                <dc:creator>Kasper Cornelia</dc:creator>
                <dc:source>Cell Communication and Signaling 2009, 7:6</dc:source>
        <dc:date>2009-03-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1478-811X-7-6</dc:identifier>
        <prism:publicationName>Cell Communication and Signaling</prism:publicationName>
        <prism:issn>1478-811X</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2009-03-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
